Topic Navigating Your Care Navigating Your Care
FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma
Chimeric Antigen Receptor (CAR) T cell-therapy is on a roll. Today marks the seventh approval of CAR T therapy since the first approval in 2017.
Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) today approved the CAR T-cell treatment axicabtagene ciloleucel (Yescarta®) for patients with follicular l…
Meet The Researcher: Dr. Rayne Rouce
To commemorate Black History Month, LLS is highlighting exceptional clinicians and healthcare professionals throughout the month of February. Dr. Rayn…
Practicing Self-Advocacy During My PTCL Journey
The LLS Blog invites Aaron, who was diagnosed with peripheral T-cell lymphoma (PTCL), to share his reflections on becoming a self-advocate throughout …
Honoring My Daughter’s Legacy By Continuing Her Fight
Today is International Childhood Cancer Day, a day that had little significance for me less than four short years ago. In October 2017, I heard the wo…
Topic Dare to Dream Dare to Dream
Ushering In a New Era of Pediatric Blood Cancer Treatment and Care
We caught up with Gwen Nichols, MD, Chief Medical Officer at The Leukemia & Lymphoma Society (LLS), to share the progress we’re making to bring cures …
Helping Blood Cancer Patients and Families When It's Needed Most
In honor of Blood Cancer Awareness Month, Dr. Gwen Nichols reflects on our vital work to support blood cancer patients and their families.
Topic Navigating Your Care Navigating Your Care
A New CAR-T Approval Brings Hope for Mantle Cell Lymphoma Patients
Meet the Researcher: Omar Abdel-Wahab, MD
Dr. Abdel-Wahab of Memorial Sloan Kettering Cancer Center focuses on an area of research called epigenetics – chemical modifications that regulate (sw…
